Mar 27, 2023 / NTS GMT
Hiromitsu Ikeda - Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
Thank you very much for your participation for this meeting of Astellas' Corporate-wide Digital Transformation Driven by Analytics despite of your very busy schedule. I'm Hiro Ikeda, the VP of the Corporate advocacy in Relations division. First, let me explain you how to ask the questions for this session at the end of this meeting. (Operator Instructions) And this material is available on the website and in line with the presentation material, we would like to go through this seminar. So the participants for here today is the CTO and also Vice President, Naoki Okamura; and also Senior Director of Advanced Informatics and Analytics, Masanori Ito. So there are 2 speakers here today. This material or representation by representatives for the company and answers and statements by representatives for the company in the Q&A session includes the forward-looking statements based on assumptions and beliefs in light of the information currently available to management and subject to significant risks and uncertainties.
Astellas Pharma Inc Corporate- wide Digital Transformation Driven by Analytics Briefing Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot